Szymańska et al. reported 77% of clear-cell carcinomas from a multi-center case-control study harbor VHL mutations; in contrast, only 22% of RCCs of other histological types harbor VHL mutations [42]. This evidence concerns the gene VHL and clear cell adenocarcinoma.